Position in SCLX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$14,453
+$2,113 QoQ
Shares Held
1,853
0.0% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 23 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CREATIVE FINANCIAL DESIGNS INC /ADV holds $42,475,367 across 16 Drug Manufacturers - General names. SCLX ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,603 | $35,506,729 | |
| 2 | AMGN |
Amgen Inc
|
6,017 | $2,178,876 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,797 | $2,158,414 | |
| 4 | JNJ |
Johnson & Johnson
|
4,257 | $1,081,150 | |
| 5 | ABBV |
AbbVie Inc.
|
1,839 | $462,765 | |
| 6 | PFE |
Pfizer Inc
|
14,841 | $357,371 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,696 | $340,612 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,756 | $216,420 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,453 | 1,853 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $12,340 | 1,853 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $22,606 | 1,853 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $36,466 | 1,853 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||